Discovery & Development

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.

The blood–brain barrier is a problem for most Alzheimer’s disease therapeutics, but ultrasound can help.

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.

University of Bristol researchers target the glycocalyx to prevent diabetic retinopathy and kidney disease

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them